# C4 Therapeutics, Inc.: Form 8-K, filed Jun 21, 2021

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2021-06-21
- Accepted by EDGAR: Jun 21, 2021, 16:26 ET
- Period: 2021-06-15
- Accession: 0001564590-21-033633
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000156459021033633/cccc-8k_20210615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000156459021033633/

## Items reported

- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000156459021033633/cccc-8k_20210615.htm

Filed Jun 21, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-033633. Last ingested by Listed: Nov 13, 2026, 16:11 ET. No prices; not investment advice.